新发现的嘧啶-2,4-二胺衍生物被鉴定为有效的CDK9和CDK2抑制剂,并对包括MDA-MB-231在内的肿瘤细胞具有活性。
Novel pyrimidine-2,4-diamine derivatives were identified as potent CDK9 and CDK2 inhibitors, and were active against tumor cells including MDA-MB-231.
新发现的嘧啶-2,4-二胺衍生物被鉴定为有效的CDK9和CDK2抑制剂,并对包括MDA-MB-231在内的肿瘤细胞具有活性。